Story
Globus Medical, Pan American Silver, Kinross Gold Flagged as Under-Covered Large-Caps
Summary
An analysis has identified three large-cap companies, Globus Medical, Pan American Silver, and Kinross Gold, as potentially undervalued due to sparse Wall Street coverage despite strong earnings growth and financial health metrics.
A recent market analysis identified three large-capitalization stocks—Globus Medical (GMED), Pan American Silver (PAAS), and Kinross Gold (KGC)—that exhibit strong fundamentals but receive significantly less attention from Wall Street analysts than their peers, potentially creating a valuation gap.
The Analyst Coverage Gap
According to an August 28 report from Investing.com, the primary indicator of these companies being “under the radar” is their thin analyst coverage. While large-cap stocks are typically followed by 20 to 30 analysts, these companies have far fewer:
- Globus Medical (GMED): 13 analysts
- Kinross Gold (KGC): 10 analysts
- Pan American Silver (PAAS): 8 analysts
The report suggests this limited institutional focus may mean the companies' recent performance and future prospects are not fully priced into their stocks.
Performance vs. Valuation
AdThe analysis highlights a disconnect between the companies' recent financial results and their stock performance over the past six months. Globus Medical reported 51.5% earnings per share (EPS) growth and 19.7% revenue growth, yet its stock has declined 6.9% over the period. The medical device firm trades at a forward price-to-earnings (P/E) ratio of 16.1x.
Similarly, the two precious metals producers have posted significant growth, with Pan American Silver reporting 133% EPS growth and Kinross Gold delivering 112% EPS growth. Despite this, their stocks are down 18.1% and 7.4% respectively over the last six months, according to the report's data.
Financial Health and Associated Risks
The report also points to several indicators of financial strength. Kinross Gold holds a perfect Piotroski Score of 9, a top mark for financial health, while Globus Medical operates with a low debt-to-equity ratio of 2.3% and maintains gross margins of 69%. Pan American Silver has a 17-year history of paying dividends.
However, potential risks were also noted. Both Pan American Silver and Kinross Gold carry moderate debt levels and are subject to the inherent volatility of commodity prices. The report also mentioned that Kinross Gold's Relative Strength Index (RSI) suggests the stock may be in overbought territory in the short term, while Globus Medical is a pure growth play that does not pay a dividend.
Read next
More on Stocks
U.S. Stock Futures Rebound as Markets Digest Hawkish Fed Rate Hike
U.S. stock futures rose in overnight trading, recovering from a sell-off triggered by the Federal Reserve's first interest rate hike in three years. Falling oil prices and positive corporate news helped lift market sentiment.
Holtec Suspends $900 Million IPO Amid Challenging Market Conditions
Nuclear services company Holtec Nuclear Corp. has postponed its U.S. initial public offering, which aimed to raise as much as $900 million, citing unfavorable market conditions and weak performance from recently listed peers in the sector.
Snap Stock Climbs on Enterprise Push for New Specs AR Glasses
Shares of Snap Inc. gained in after-hours trading after the company unveiled its new $2,195 Specs AR glasses and announced key enterprise partnerships with Salesforce, Nvidia, and AWS.
Gold Prices Fall as Hawkish Fed Outlook Boosts US Dollar
Gold prices declined after the Federal Reserve raised interest rates by 25 basis points and signaled further tightening, strengthening the U.S. dollar and increasing the opportunity cost of holding the non-yielding metal.